Ready to play
Ready to play
Researchers at Tohoku University in Japan have demonstrated that experimental antibodies targeting the Nav1.7 channel associated with pain can relieve nerve pain in mice for up to four days, without affecting normal sensation or movement. The experiments showed that these two antibodies reduced electrical activity linked to pain signals, with effectiveness comparable to pregabalin after 96 hours. This suggests their potential in treating neuropathic pain while preserving normal bodily functions.
Notice: This Is an AI-Generated Summary
Comments (0)